Cogstate Limited (COGZF)

Market Cap	258.88M +110.3%
Revenue (ttm)	53.09M +22.3%
Net Income	10.14M +86.1%
EPS	0.06 +85.1%
Shares Out	n/a
PE Ratio	25.52
Forward PE	21.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,692
Open	1.510
Previous Close	1.510
Day's Range	1.510 - 1.510
52-Week Range	0.721 - 2.100
Beta	-0.04
RSI	48.08
Earnings Date	Feb 19, 2026

About Cogstate

Cogstate Limited, a neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide. It offers digital cognitive assessment, endpoint data quality (rater services), remote assessment, scientific consulting, healthcare cognitive screening, and research and academic collaboration solutions for various therapeutic areas, including Alzheimer’s disease and dementia, preclinical Alzheimer’s disease, pediatrics and rare disease, Parkinson’s disease, multiple sclerosis, schizophre...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1999
• Employees: 148
• Stock Exchange: OTCMKTS
• Ticker Symbol: COGZF

Financial Performance

In fiscal year 2025, Cogstate's revenue was $53.09 million, an increase of 22.25% compared to the previous year's $43.43 million. Earnings were $10.14 million, an increase of 86.15%.